These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15139048)

  • 21. Analysis of the time interval between diagnoses in women with double primary breast and ovarian or primary peritoneal cancers.
    Olawaiye A; Caesar L; Walsh D; Lyman M; Yeh J; Rodabaugh K; Marchetti D; Lele S; Odunsi K
    Gynecol Oncol; 2004 Sep; 94(3):796-802. PubMed ID: 15350375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers.
    Metcalfe K; Lynch HT; Ghadirian P; Tung N; Olivotto I; Warner E; Olopade OI; Eisen A; Weber B; McLennan J; Sun P; Foulkes WD; Narod SA
    J Clin Oncol; 2004 Jun; 22(12):2328-35. PubMed ID: 15197194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Feasibility of breast-conserving surgery for patients with breast carcinoma associated with nipple discharge.
    Cabioglu N; Krishnamurthy S; Kuerer HM; Hunt KK; Singletary SE; Meric-Bernstam F; Ross MI; Feig BW; Ames FC; Babiera GV
    Cancer; 2004 Aug; 101(3):508-17. PubMed ID: 15274063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytokeratin-positive cells in sentinel lymph nodes in breast cancer are not random events: experience in patients undergoing prophylactic mastectomy.
    King TA; Ganaraj A; Fey JV; Tan LK; Hudis C; Norton L; Cody HS; Borgen PI
    Cancer; 2004 Sep; 101(5):926-33. PubMed ID: 15329899
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
    Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
    J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of a tool for identifying women at high risk for hereditary breast cancer in population-based screening.
    Hoskins KF; Zwaagstra A; Ranz M
    Cancer; 2006 Oct; 107(8):1769-76. PubMed ID: 16967460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Familial breast cancer: characteristics and outcome of BRCA 1-2 positive and negative cases.
    Veronesi A; de Giacomi C; Magri MD; Lombardi D; Zanetti M; Scuderi C; Dolcetti R; Viel A; Crivellari D; Bidoli E; Boiocchi M
    BMC Cancer; 2005 Jul; 5():70. PubMed ID: 15996267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Probably benign lesions at breast magnetic resonance imaging: preliminary experience in high-risk women.
    Liberman L; Morris EA; Benton CL; Abramson AF; Dershaw DD
    Cancer; 2003 Jul; 98(2):377-88. PubMed ID: 12872360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early detection of breast and ovarian cancer in families with BRCA mutations.
    Vasen HF; Tesfay E; Boonstra H; Mourits MJ; Rutgers E; Verheyen R; Oosterwijk J; Beex L
    Eur J Cancer; 2005 Mar; 41(4):549-54. PubMed ID: 15737559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma.
    Rabban JT; Barnes M; Chen LM; Powell CB; Crawford B; Zaloudek CJ
    Am J Surg Pathol; 2009 Aug; 33(8):1125-36. PubMed ID: 19440148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening for hereditary breast cancer.
    Dent R; Warner E
    Semin Oncol; 2007 Oct; 34(5):392-400. PubMed ID: 17920893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening and follow-up of the patient at high risk for breast cancer.
    Willey SC; Cocilovo C
    Obstet Gynecol; 2007 Dec; 110(6):1404-16. PubMed ID: 18055740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High incidence of BRCA1-2 germline mutations, previous breast cancer and familial cancer history in Jewish patients with uterine serous papillary carcinoma.
    Biron-Shental T; Drucker L; Altaras M; Bernheim J; Fishman A
    Eur J Surg Oncol; 2006 Dec; 32(10):1097-100. PubMed ID: 16650962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heterogenic loss of the wild-type BRCA allele in human breast tumorigenesis.
    King TA; Li W; Brogi E; Yee CJ; Gemignani ML; Olvera N; Levine DA; Norton L; Robson ME; Offit K; Borgen PI; Boyd J
    Ann Surg Oncol; 2007 Sep; 14(9):2510-8. PubMed ID: 17597348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Results of MRI screening for breast cancer in high-risk patients with LCIS and atypical hyperplasia.
    Port ER; Park A; Borgen PI; Morris E; Montgomery LL
    Ann Surg Oncol; 2007 Mar; 14(3):1051-7. PubMed ID: 17206485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breast cancer detection and tumor characteristics in BRCA1 and BRCA2 mutation carriers.
    Krammer J; Pinker-Domenig K; Robson ME; Gönen M; Bernard-Davila B; Morris EA; Mangino DA; Jochelson MS
    Breast Cancer Res Treat; 2017 Jun; 163(3):565-571. PubMed ID: 28343309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BMRI in early detection of breast cancer in patients with increased genetic risk: our preliminary results.
    Trecate G; Vergnaghi D; Bergonzi S; De Simone T; Costa C; Spatti GB; Pasini B; Musumeci R
    J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):125-30. PubMed ID: 12585666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival of patients with BRCA1-associated breast cancer diagnosed in an MRI-based surveillance program.
    Møller P; Stormorken A; Jonsrud C; Holmen MM; Hagen AI; Clark N; Vabø A; Sun P; Narod SA; Mæhle L
    Breast Cancer Res Treat; 2013 May; 139(1):155-61. PubMed ID: 23615785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stage of breast cancers found during the surveillance of women with a familial or hereditary risk.
    Kaas R; Muller SH; Hart AA; Rutgers EJ
    Eur J Surg Oncol; 2008 May; 34(5):501-7. PubMed ID: 17555911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sensitivity of MRI versus conventional screening in the diagnosis of BRCA-associated breast cancer in a national prospective series.
    Hagen AI; Kvistad KA; Maehle L; Holmen MM; Aase H; Styr B; Vabø A; Apold J; Skaane P; Møller P
    Breast; 2007 Aug; 16(4):367-74. PubMed ID: 17317184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.